Drug Metabolism Reviews

Papers
(The TQCC of Drug Metabolism Reviews is 8. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-09-01 to 2025-09-01.)
ArticleCitations
The annoying flaws of gerontological research38
Cell-Biomaterial constructs for wound healing and skin regeneration35
Drug transporters in drug disposition – the year 2022 in review29
Enantioselectivity in some physiological and pathophysiological roles of hydroxyeicosatetraenoic acids28
Differential modulation of cytochrome P450 enzymes by arsenicals in non-human experimental models21
New strategy for rational use of antihypertensive drugs in clinical practice in high-altitude hypoxic environments20
An in-depth review of PPARγ modulators as anti-diabetes therapeutics20
Mechanisms of intestinal pharmacokinetic natural product-drug interactions19
Cytochrome P450-mediated carbon-carbon bond formation in drug metabolism18
Assessing and mitigating pH-mediated DDI risks in drug development – formulation approaches and clinical considerations15
Biopolymers as promising vehicles for drug delivery to the brain13
Drug transporters in drug disposition – highlights from the year 202413
Metabolic activation of tyrosine kinase inhibitors: recent advance and further clinical practice12
Transporter-mediated drug-drug interactions: regulatory guidelines, in vitro and in vivo methodologies and translation, special population12
Metabolism of new drug modalities research advances – 2024 year in review12
Genetic determinants of paclitaxel-induced peripheral neuropathy: a review of current literature12
Clinical pharmacokinetics of nebivolol: a systematic review11
A transcriptional regulatory network of HNF4α and HNF1α involved in human diseases and drug metabolism11
Scaling factors to inform in vitro - in vivo extrapolation from preclinical and livestock animals: state of the field and recommendations 11
Favipiravir, remdesivir, and lopinavir: metabolites, degradation products and their analytical methods9
In silico ADME and target prediction studies of Alogliptin as drug molecule8
Impact of DNA methylation on ADME gene expression, drug disposition, and efficacy8
Effects of intestinal flora on pharmacokinetics and pharmacodynamics of drugs8
Advances in drug resistance of osteosarcoma caused by pregnane X receptor8
0.031028032302856